Gemcitabine and capecitabine for advanced biliary cancer

BACKGROUND: Gemcitabine with capecitabine (gem-cap) is an established regimen for advanced biliary cancer (ABC) supported by our previously reported phase II trial. Here, we provide our updated experience. METHODS: Single institution, retrospective study from 2005 to 2015 of ABC treated with gem-cap...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Gastrointest Oncol
Autors principals: Gabriel, Emmanuel, Gandhi, Shipra, Attwood, Kristopher, Kuvshinoff, Boris, Hochwald, Steven, Iyer, Renuka
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5582046/
https://ncbi.nlm.nih.gov/pubmed/28890824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.01.24
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars